Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 131

1.

Separate episodes of capillary leak syndrome and pulmonary hypertension after adjuvant gemcitabine and three years later after nab-paclitaxel for metastatic disease.

Casadei Gardini A, Aquilina M, Oboldi D, Lucchesi A, Carloni S, Tenti E, Burgio MA, Amadori D, Frassineti GL.

BMC Cancer. 2013 Nov 12;13:542. doi: 10.1186/1471-2407-13-542.

PMID:
24215543
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

A phase I trial of nab-paclitaxel, gemcitabine, and capecitabine for metastatic pancreatic cancer.

Ko AH, Truong TG, Kantoff E, Jones KA, Dito E, Ong A, Tempero MA.

Cancer Chemother Pharmacol. 2012 Dec;70(6):875-81. doi: 10.1007/s00280-012-1979-7. Epub 2012 Sep 28.

PMID:
23053263
[PubMed - indexed for MEDLINE]
3.

Sustained response with gemcitabine plus Nab-paclitaxel after folfirinox failure in metastatic pancreatic cancer: report of an effective new strategy.

Portal A, Pernot S, Siauve N, Landi B, Lepère C, Colussi O, Rougier P, Zaanan A, Verrière B, Taieb J.

Clin Res Hepatol Gastroenterol. 2014 Apr;38(2):e23-6. doi: 10.1016/j.clinre.2014.01.005. Epub 2014 Feb 18.

PMID:
24559766
[PubMed - indexed for MEDLINE]
4.

Phase I/II study of albumin-bound nab-paclitaxel plus gemcitabine administered to Chinese patients with advanced pancreatic cancer.

Zhang DS, Wang DS, Wang ZQ, Wang FH, Luo HY, Qiu MZ, Wang F, Li YH, Xu RH.

Cancer Chemother Pharmacol. 2013 Apr;71(4):1065-72. doi: 10.1007/s00280-013-2102-4. Epub 2013 Mar 13.

PMID:
23483298
[PubMed - indexed for MEDLINE]
5.

Comparative benefits of Nab-paclitaxel over gemcitabine or polysorbate-based docetaxel in experimental pancreatic cancer.

Awasthi N, Zhang C, Schwarz AM, Hinz S, Wang C, Williams NS, Schwarz MA, Schwarz RE.

Carcinogenesis. 2013 Oct;34(10):2361-9. doi: 10.1093/carcin/bgt227. Epub 2013 Jun 26.

PMID:
23803690
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Severe gemcitabine-induced capillary-leak syndrome mimicking cardiac failure in a patient with advanced pancreatic cancer and high-risk cardiovascular disease.

Biswas S, Nik S, Corrie PG.

Clin Oncol (R Coll Radiol). 2004 Dec;16(8):577-9.

PMID:
15630853
[PubMed - indexed for MEDLINE]
7.

[Anasarca, a complication of chemotherapy with gemcitabine in two patients with pancreatic cancer].

Dahan L, Ressiot E, Cournede A, Ries P, Duluc M, Laquiere A, Laugier R, Braguer D, Seitz JF.

Gastroenterol Clin Biol. 2007 Dec;31(12):1143-5. French.

PMID:
18176375
[PubMed - indexed for MEDLINE]
Free Article
8.

Gemcitabine-induced systemic capillary leak syndrome.

De Pas T, Curigliano G, Franceschelli L, Catania C, Spaggiari L, de Braud F.

Ann Oncol. 2001 Nov;12(11):1651-2.

PMID:
11822767
[PubMed - indexed for MEDLINE]
Free Article
9.
10.

Treatment of metastatic pancreatic adenocarcinoma: a review.

Thota R, Pauff JM, Berlin JD.

Oncology (Williston Park). 2014 Jan;28(1):70-4. Review.

PMID:
24683721
[PubMed - indexed for MEDLINE]
Free Article
11.

Successful treatment with nab-paclitaxel and gemcitabine after FOLFIRINOX failure in a patient with metastasized pancreatic adenocarcinoma.

Berger AK, Weber TF, Jäger D, Springfeld C.

Onkologie. 2013;36(12):763-5. doi: 10.1159/000356811. Epub 2013 Nov 20.

PMID:
24356569
[PubMed - indexed for MEDLINE]
12.

[A case of drug-induced interstitial pneumonitis after adjuvant chemotherapy with gemcitabine for pancreatic cancer].

Ho Kim D, Shiozawa S, Tsuchiya A, Usui T, Inose S, Aizawa M, Yoshimatsu K, Katsube T, Naritaka Y, Ogawa K.

Gan To Kagaku Ryoho. 2008 Jan;35(1):133-6. Japanese.

PMID:
18195543
[PubMed - indexed for MEDLINE]
13.

Phase I/IIa study of cisplatin and gemcitabine as induction chemotherapy followed by concurrent chemoradiotherapy with gemcitabine and paclitaxel for locally advanced non-small-cell lung cancer.

Divers SG, Spencer SA, Carey D, Busby EM, Hyatt MD, Robert F.

J Clin Oncol. 2005 Sep 20;23(27):6664-73.

PMID:
16170174
[PubMed - indexed for MEDLINE]
Free Article
14.

A phase II trial of nab-Paclitaxel as second-line therapy in patients with advanced pancreatic cancer.

Hosein PJ, de Lima Lopes G Jr, Pastorini VH, Gomez C, Macintyre J, Zayas G, Reis I, Montero AJ, Merchan JR, Rocha Lima CM.

Am J Clin Oncol. 2013 Apr;36(2):151-6. doi: 10.1097/COC.0b013e3182436e8c.

PMID:
22307213
[PubMed - indexed for MEDLINE]
15.

A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.

Clegg A, Scott DA, Sidhu M, Hewitson P, Waugh N.

Health Technol Assess. 2001;5(32):1-195. Review.

PMID:
12065068
[PubMed - indexed for MEDLINE]
Free Article
16.

Stromal disrupting effects of nab-paclitaxel in pancreatic cancer.

Alvarez R, Musteanu M, Garcia-Garcia E, Lopez-Casas PP, Megias D, Guerra C, Muñoz M, Quijano Y, Cubillo A, Rodriguez-Pascual J, Plaza C, de Vicente E, Prados S, Tabernero S, Barbacid M, Lopez-Rios F, Hidalgo M.

Br J Cancer. 2013 Aug 20;109(4):926-33. doi: 10.1038/bjc.2013.415. Epub 2013 Aug 1.

PMID:
23907428
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Paclitaxel albumin-bound particles (abraxane) in combination with bevacizumab with or without gemcitabine: early experience at the University of Miami/Braman Family Breast Cancer Institute.

Lobo C, Lopes G, Silva O, Gluck S.

Biomed Pharmacother. 2007 Oct;61(9):531-3. Epub 2007 Sep 12.

PMID:
17913443
[PubMed - indexed for MEDLINE]
18.

nab-Paclitaxel potentiates gemcitabine activity by reducing cytidine deaminase levels in a mouse model of pancreatic cancer.

Frese KK, Neesse A, Cook N, Bapiro TE, Lolkema MP, Jodrell DI, Tuveson DA.

Cancer Discov. 2012 Mar;2(3):260-9. doi: 10.1158/2159-8290.CD-11-0242. Epub 2012 Feb 28.

PMID:
22585996
[PubMed - indexed for MEDLINE]
19.

A phase I study of hepatic arterial infusion of nab-paclitaxel in combination with intravenous gemcitabine and bevacizumab for patients with advanced cancers and predominant liver metastases.

Tsimberidou AM, Ye Y, Wheler J, Naing A, Hong D, Nwosu U, Hess KR, Wolff RA.

Cancer Chemother Pharmacol. 2013 Apr;71(4):955-63. doi: 10.1007/s00280-013-2088-y. Epub 2013 Feb 3.

PMID:
23377373
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Phase I trial of nanoparticle albumin-bound paclitaxel in combination with gemcitabine in patients with thoracic malignancies.

Stinchcombe TE, Socinski MA, Lee CB, Hayes DN, Moore DT, Goldberg RM, Dees EC.

J Thorac Oncol. 2008 May;3(5):521-6. doi: 10.1097/JTO.0b013e31816de2a7.

PMID:
18449006
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk